As of 3:59pm ET
| -0.0148 / -1.86%|
The 2 analysts offering 12-month price forecasts for Bio Path Holdings Inc have a median target of 3.25, with a high estimate of 4.50 and a low estimate of 2.00. The median estimate represents a +316.45% increase from the last price of 0.78.
The current consensus among 2 polled investment analysts is to Buy stock in Bio Path Holdings Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.